Matthew Dryden

9.6k citations

125 papers · 5.7k indexed · 1 hit paper · h-index 38

Impact in

Applied Microbiology and Biotechnology top 0.2%
- Antibiotic Use and Resistance
Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing

Papers in

Applied Microbiology and Biotechnology 19
- Antibiotic Use and Resistance 19
Clinical Biochemistry 42
- Bacterial Identification and Susceptibility Testing 42

Co-authors: Jonathan Cooke Thomas Patton James Brennan John N. Barrett Christopher Dunnill Nikolaos T. Georgopoulos David Leaper Dilip Nathwani
Journals: Journal of Antimicrobial Chemotherapy (18 papers)International Journal of Antimicrobial Agents (10 papers)Journal of Hospital Infection (5 papers)Clinical Microbiology and Infection (4 papers)Infection (4 papers)
Partner nations: United Kingdom United States Spain

In The Last Decade

Matthew Dryden

121 papers receiving 5.5k citations

Hit Papers

align trajectories log scale

Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS‐modulating technologies for augmentation of the healing process 2015 · 1.0k citations

Peers

Countries citing papers authored by Matthew Dryden

Since Specialization

Citations

This map shows the geographic impact of Matthew Dryden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Dryden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Dryden more than expected).

Fields of papers citing papers by Matthew Dryden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Dryden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Dryden. The network helps show where Matthew Dryden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matthew Dryden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Dryden Line = papers co-authored together Matthew Dryden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The United Nations’ General Assembly High-Level Meeting on antimicrobial resistance: a joint statement from the Heads of Government and Chief Medical Officers of the United Kingdom’s Overseas Territories Journal of Antimicrobial Chemotherapy ·Matthew Dryden, 徐芷君, Natalie Wright, All Rizky Ramadhan, 康新婷, Shaun Ramroop, Johanna M. Zimmermann, Robin Mertens, D Provenzano, 郝德靖, Helen Carter, Peter Moss, Christin Hoffmann, Maduru Lakshmi Rupa, Hye Yeon Park, Kevin P. Donovan	2024	1
2	International Validation of a Methicillin-Resistant Staphylococcus aureus Risk Assessment Tool for Skin and Soft Tissue Infections Infectious Diseases and Therapy ·Evan J Zasowski, Trang D Trinh, Kimberly C. Claeys, Matthew Dryden, Sergey Shlyapnikov, Matteo Bassetti, Alessia Carnelutti, Sagar P. Mohammad, Asok Kurup, Leslie Landmark, Laura Marcela Herrera Medina, Bing Cao, Michael J. Rybak	2022	6
3	A retrospective observational study of Lyme neuroborreliosis in the southwest of England Clinical Infection in Practice ·Christina Petridou, Joanna Lovett, Amy Russell, R Chen, Magaly Cruz Torres, Assis Shikida, Kordo Saeed, Mihye Lee, Matthew Dryden	2020	2
4	Antimicrobial activity of a novel bioengineered honey against non-typeable Haemophilus influenzae biofilms: an in vitro study Journal of Clinical Pathology ·Navaneetham Subramaniam, Matthew Dryden, R N Allan, Rami J. Salib	2018	9
5	Hot topics in necrotising skin and soft tissue infections International Journal of Antimicrobial Agents ·Kordo Saeed, Silvano Esposito, Ian M. Gould, Tiziana Ascione, Matteo Bassetti, É. Bonnet, Emilio Bouza, Mónica Chan, Joshua S. Davis, Giuseppe De Simone, Matthew Dryden, Thomas Gottlieb, Karolin Hijazi, David Chien Lye, Pasquale Pagliano, Christina Petridou, Elda Righi, John Segreti, Serhat Ünal, Ata Nevzat Yalçın	2018	20
6	Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe Diagnostic Microbiology and Infectious Disease ·David B. Huang, Sophie Magnet, Stefania De Angelis, Thomas L Holland, Thomas M. File, Matthew Dryden, G. Ralph Corey, Antoni Torres, Mark H. Wilcox	2018	12
7	Reactive oxygen: A novel antimicrobial mechanism for targeting biofilm-associated infection Journal of Global Antimicrobial Resistance ·Matthew Dryden, Jonathan Cooke, Rami J. Salib, Gertraud Maier-Bode, Timothy C. Biggs, 唯佐野, R N Allan, Navaneetham Subramaniam, Fenella Halstead, Beryl Oppenheim, Thomas J. Hall, Sophie C. Cox, Liam M. Grover, Suhaeni Suhaeni, Lilyann Novak Frazer, Malcolm Richardson	2017	38
8	Learning points from a case of severe amoebic colitis. ePrints Soton (University of Southampton) ·Christina Petridou, Mohammad Aprizal, Daewoong Pharmaceutical Co. Ltd., Matthew Dryden, Kordo Saeed	2017	4
9	Hot topics in reactive oxygen therapy: Antimicrobial and immunological mechanisms, safety and clinical applications Journal of Global Antimicrobial Resistance ·Matthew Dryden, Jonathan Cooke, Rami J. Salib, Gertraud Maier-Bode, Sylvia L. F. Pender, Jill Brooks	2017	35
10	Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe Diagnostic Microbiology and Infectious Disease ·David B. Huang, Thomas M. File, Matthew Dryden, G. Ralph Corey, Antoni Torres, Mark H. Wilcox	2017	16
11	The antimicrobial activity of prototype modified honeys that generate reactive oxygen species (ROS) hydrogen peroxide BMC Research Notes ·Jonathan Cooke, Matthew Dryden, Thomas Patton, James Brennan, John N. Barrett	2015	70
12	Fusobacterium species infections: clinical spectrum and outcomes at a district general hospital Infection ·速人木下, Kordo Saeed, Matthew Dryden	2013	19
13	Tigecycline: an antibiotic for the twenty-first century Journal of Antimicrobial Chemotherapy ·Matthew Dryden	2013	9
14	Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and aseptic loosening Infection ·Kordo Saeed, Matthew Dryden, Valérie Franc, Gregory White	2013	21
15	Carriage rates, circulating serotypes and antibiotic resistance among Streptococcus pneumoniae in healthy infants in Yei, South Sudan Kisun Jun, Johanna M. Jefferies, A Slavgorodska, Henry A. Mosquera, Stuart C. Clarke, Matthew Dryden	2011	1
16	A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections Journal of Antimicrobial Chemotherapy ·Inge C. Gyssens, Matthew Dryden, P. Kujath, Dilip Nathwani, Nicolaas C. Schaper, B Hampel, Peter Reimnitz, Jeff Alder, Pierre Arvis	2011	48
17	Using antibiotics responsibly: right drug, right time, right dose, right duration Journal of Antimicrobial Chemotherapy ·Matthew Dryden, Alan P. Johnson, Diane Ashiru‐Oredope, Mike Sharland	2011	100
18	Complicated Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus : Epidemiology, Risk Factors, and Presentation Surgical Infections ·Matthew Dryden	2008	32
19	Cryptosporidial diarrhoea in AIDS and its treatment. Gut ·G M Connolly, Matthew Dryden, D.C. Shanson, Brian Gazzard	1988	104
20	My student elective. Along the White Nile. BMJ ·Matthew Dryden	1983	1

About Matthew Dryden

Matthew Dryden is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry, Infectious Diseases, Critical Care and Intensive Care Medicine and Parasitology, having authored 125 papers that have together received 5.7k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (44 papers), Bacterial Identification and Susceptibility Testing (42 papers), Streptococcal Infections and Treatments (28 papers), Antibiotic Use and Resistance (19 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Pneumonia and Respiratory Infections (9 papers), Nosocomial Infections in ICU (8 papers) and Clostridium difficile and Clostridium perfringens research (8 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (548 citations), Clinical Biochemistry (1.2k citations), Rehabilitation (847 citations), Infectious Diseases (2.2k citations) and Molecular Medicine (396 citations). Matthew Dryden has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Jonathan Cooke, Thomas Patton, James Brennan, John N. Barrett, Christopher Dunnill, Nikolaos T. Georgopoulos, David Leaper, Dilip Nathwani, John A. Weigelt and Kordo Saeed. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, Journal of Hospital Infection, Clinical Microbiology and Infection and Infection.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact